Endocannabinoid-mediated control of synaptic transmission.
暂无分享,去创建一个
Masahiko Watanabe | Masanobu Kano | Masahiko Watanabe | M. Kano | T. Ohno‐Shosaku | Y. Hashimotodani | M. Uchigashima | Motokazu Uchigashima | Yuki Hashimotodani | Takako Ohno-Shosaku | T. Ohno-Shosaku
[1] P. Mitchell,et al. Depression and anxiety with rimonabant , 2007, The Lancet.
[2] D. Feldman,et al. Long-term depression induced by sensory deprivation during cortical map plasticity in vivo , 2003, Nature Neuroscience.
[3] A. Levey,et al. Localization of M2 muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus , 2000, Neuroscience Letters.
[4] J. D. Richardson,et al. Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia , 1998, The Journal of Neuroscience.
[5] J. Rossier,et al. Absolute quantification of AMPA receptor subunit mRNAs in single hippocampal neurons , 2001, Journal of neurochemistry.
[6] L. Petrocellis,et al. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. , 2000, The Biochemical journal.
[7] K. Connolly,et al. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids , 2001, Neuroscience Letters.
[8] C. Hillard,et al. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. , 2000, Chemistry and physics of lipids.
[9] W. Regehr,et al. Endocannabinoids Inhibit Transmission at Granule Cell to Purkinje Cell Synapses by Modulating Three Types of Presynaptic Calcium Channels , 2004, The Journal of Neuroscience.
[10] D. Tregouet,et al. Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men. , 2007, The Journal of clinical endocrinology and metabolism.
[11] M. Christie,et al. Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro , 2001, The Journal of physiology.
[12] N. Stella,et al. Receptor-dependent formation of endogenous cannabinoids in cortical neurons. , 2001, European journal of pharmacology.
[13] Yue Wang,et al. Induction of LTD in the dentate gyrus in vitro is NMDA receptor independent, but dependent on Ca2+ influx via low-voltage-activated Ca2+ channels and release of Ca2+ from intracellular stores. , 1997, Journal of neurophysiology.
[14] G. Marsicano,et al. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain , 2002, Neuroscience.
[15] J. Crystal,et al. An endocannabinoid mechanism for stress-induced analgesia , 2005, Nature.
[16] M. Kano,et al. Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release , 2008, Neuropharmacology.
[17] J. Lacaille,et al. Cell‐type specific GABA synaptic transmission and activity‐dependent plasticity in rat hippocampal stratum radiatum interneurons , 2005, The European journal of neuroscience.
[18] K. Mackie,et al. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors , 2007, Nature Neuroscience.
[19] D. Macneil,et al. Distribution of orexin receptor mRNA in the rat brain , 1998, FEBS letters.
[20] B. Koller,et al. Altered inflammatory responses in leukotriene-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[21] K. Mackie,et al. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. B. Roberts,et al. Suppression of NMDA receptor function using antisense DNA block ocular dominance plasticity while preserving visual responses. , 1998, Journal of neurophysiology.
[23] J. Shim,et al. CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. , 2002, Chemistry and physics of lipids.
[24] Masahiko Watanabe,et al. Depolarization‐induced suppression of inhibition mediated by endocannabinoids at synapses from fast‐spiking interneurons to medium spiny neurons in the striatum , 2006, The European journal of neuroscience.
[25] C. Funk,et al. Disruption of 12/15-Lipoxygenase Expression in Peritoneal Macrophages , 1996, The Journal of Biological Chemistry.
[26] S. Nakanishi,et al. Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. , 1992, The Journal of biological chemistry.
[27] K Williams,et al. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. , 1993, Molecular pharmacology.
[28] J. Schwartz,et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons , 1994, Nature.
[29] A. Schierloh,et al. Cannabinoid Receptor Type 1 Located on Presynaptic Terminals of Principal Neurons in the Forebrain Controls Glutamatergic Synaptic Transmission , 2006, The Journal of Neuroscience.
[30] L. Petrocellis,et al. Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain , 2008, Neuroscience.
[31] E. Marco,et al. Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats , 2003, Pharmacology Biochemistry and Behavior.
[32] Stephen P. H. Alexander,et al. Influence of Cannabinoids on Electrically Evoked Dopamine Release and Cyclic AMP Generation in the Rat Striatum , 1997, Journal of neurochemistry.
[33] M. Storozhuk,et al. Presence of depolarization-induced suppression of inhibition in a fraction of GABAergic synaptic connections in rat neocortical cultures. , 2005, Neuroscience and behavioral physiology.
[34] J. Rossier,et al. Cerebral Cortex doi:10.1093/cercor/bhj081 Cortical Sources of CRF, NKB, and CCK and Their Effects on Pyramidal Cells , 2005 .
[35] S. Snyder,et al. Differential immunohistochemical localization of inositol 1,4,5- trisphosphate- and ryanodine-sensitive Ca2+ release channels in rat brain , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] P. Somogyi,et al. The metabotropic glutamate receptor (mGluRlα) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction , 1993, Neuron.
[37] P. J. Sjöström,et al. Rate, Timing, and Cooperativity Jointly Determine Cortical Synaptic Plasticity , 2001, Neuron.
[38] Masahiko Watanabe,et al. Signaling complex formation of phospholipase Cβ4 with metabotropic glutamate receptor type 1α and 1,4,5‐trisphosphate receptor at the perisynapse and endoplasmic reticulum in the mouse brain , 2004, The European journal of neuroscience.
[39] T. Freund,et al. Immunocytochemically defined interneuron populations in the hippocampus of mouse strains used in transgenic technology , 2004, Hippocampus.
[40] J. Barker,et al. Functional properties of ryanodine receptors in hippocampal neurons change during early differentiation in culture. , 2002, Journal of neurophysiology.
[41] D. Jane,et al. Pharmacological agents acting at subtypes of metabotropic glutamate receptors , 1999, Neuropharmacology.
[42] S. Carr,et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.
[43] J. Rossier,et al. Subunit composition at the single-cell level explains functional properties of a glutamate-gated channel , 1994, Neuron.
[44] M. Morales,et al. Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5‐HT3A) are co‐expressed in GABA neurons in the rat telencephalon , 2004, The Journal of comparative neurology.
[45] G. Milligan,et al. Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function* , 2006, Journal of Biological Chemistry.
[46] D. Lovinger,et al. Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. , 2001, Journal of neurophysiology.
[47] A. Grace,et al. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction , 2006, Cellular and Molecular Life Sciences CMLS.
[48] Pankaj Sah,et al. Nuclear Calcium Signaling Evoked by Cholinergic Stimulation in Hippocampal CA1 Pyramidal Neurons , 2002, The Journal of Neuroscience.
[49] G. Uhl,et al. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain , 2006, Brain Research.
[50] W. Yung,et al. Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist , 1998, Neuroreport.
[51] I. Llano,et al. The retrograde inhibition of IPSCs in rat cerebellar Purkinje cells is highly sensitive to intracellular Ca2+ , 2000, The European journal of neuroscience.
[52] W. Regehr,et al. Serotonin Evokes Endocannabinoid Release and Retrogradely Suppresses Excitatory Synapses , 2008, The Journal of Neuroscience.
[53] M. Bear,et al. Synaptic plasticity: LTP and LTD , 1994, Current Opinion in Neurobiology.
[54] Masahiko Watanabe,et al. The CB1 Cannabinoid Receptor Is the Major Cannabinoid Receptor at Excitatory Presynaptic Sites in the Hippocampus and Cerebellum , 2006, The Journal of Neuroscience.
[55] R. Hampson,et al. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats , 2008, Psychopharmacology.
[56] C. Vaughan,et al. Multiple metabotropic glutamate receptor subtypes modulate GABAergic neurotransmission in rat periaqueductal grey neurons in vitro , 2004, Neuropharmacology.
[57] S. Treistman,et al. Distinct intracellular calcium profiles following influx through N- versus L-type calcium channels: role of Ca2+-induced Ca2+ release. , 2004, Journal of neurophysiology.
[58] T. Yoshioka,et al. Calcium-independent inhibition of GABAA current by caffeine in hippocampal slices , 2004, Brain Research.
[59] Yuriy Pankratov,et al. Somatodendritic Release of Glutamate Regulates Synaptic Inhibition in Cerebellar Purkinje Cells via Autocrine mGluR1 Activation , 2007, The Journal of Neuroscience.
[60] M. Kathmann,et al. Modulation of transmitter release via presynaptic cannabinoid receptors. , 2001, Trends in pharmacological sciences.
[61] B. Cravatt,et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[62] S. Kombian,et al. Dendritically Released Peptides Act as Retrograde Modulators of Afferent Excitation in the Supraoptic Nucleus In Vitro , 1997, Neuron.
[63] K. Mackie,et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. , 1995, Molecular pharmacology.
[64] F. Pamplona,et al. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors , 2006, Neuroscience Letters.
[65] L. Abbott,et al. Competitive Hebbian learning through spike-timing-dependent synaptic plasticity , 2000, Nature Neuroscience.
[66] L. Garey,et al. Distribution of preprosomatostatin mRNA in the rat parietal and temporal cortex. , 1994, Brain research. Molecular brain research.
[67] Beat Lutz,et al. The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus , 2006, Neuron.
[68] J. Hoenicka,et al. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1) , 2005, The Pharmacogenomics Journal.
[69] David Robbe,et al. A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity , 2004, Nature Neuroscience.
[70] R. Maldonado,et al. Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol , 2002, Psychopharmacology.
[71] S. File,et al. Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats , 2004, Behavioural pharmacology.
[72] Raphael Mechoulam,et al. CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition , 2005 .
[73] D. Lovinger,et al. Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[74] M. Kano,et al. Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus , 2007, The Journal of Neuroscience.
[75] Masahiko Watanabe,et al. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2‐mediated direct suppression and M1/M3‐mediated indirect suppression through endocannabinoid signalling , 2004, The European journal of neuroscience.
[76] W. Yung,et al. Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium , 1998, Neuroscience Letters.
[77] Michael Häusser,et al. Dendritic Calcium Spikes Are Tunable Triggers of Cannabinoid Release and Short-Term Synaptic Plasticity in Cerebellar Purkinje Neurons , 2006, The Journal of Neuroscience.
[78] D. Piomelli,et al. Carrier‐mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2‐arachidonylglycerol , 2000, Neuroreport.
[79] Takaaki AbeS,et al. Molecular Characterization of a Novel Metabotropic Glutamate Receptor mGluR 5 Coupled to Inositol Phosphate / Ca 2 + Signal Transduction , 2001 .
[80] B. Alger,et al. Direct depolarization and antidromic action potentials transiently suppress dendritic IPSPs in hippocampal CA1 pyramidal cells. , 2001, Journal of neurophysiology.
[81] J. Johnston,et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.
[82] D. Deutsch,et al. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry , 1998, Neuroscience Letters.
[83] Frank Kirchhoff,et al. Lack of the Kir4.1 channel subunit abolishes K+ buffering properties of astrocytes in the ventral respiratory group: impact on extracellular K+ regulation. , 2006, Journal of neurophysiology.
[84] D. Clapham,et al. Nucleoplasmic and cytoplasmic differences in the fluorescence properties of the calcium indicator Fluo-3. , 1997, Cell calcium.
[85] K. Starke,et al. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum , 1998, Neuroscience.
[86] J. Flier,et al. Obesity and the Hypothalamus: Novel Peptides for New Pathways , 1998, Cell.
[87] C. Ashby,et al. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. , 1996, The Journal of pharmacology and experimental therapeutics.
[88] K. Mackie,et al. Metabotropic suppression of excitation in murine autaptic hippocampal neurons , 2007, The Journal of physiology.
[89] I. Soltesz,et al. Cell type–specific gating of perisomatic inhibition by cholecystokinin , 2007, Nature Neuroscience.
[90] M. Kaghad,et al. An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.
[91] David A Lewis,et al. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. , 2006, Cerebral cortex.
[92] V. Marzo,et al. Cannabinoid receptors and their role in neuroprotection , 2007, NeuroMolecular Medicine.
[93] J. Palacios,et al. The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution , 1990, Neuroscience.
[94] H. Markram,et al. Anatomical, physiological and molecular properties of Martinotti cells in the somatosensory cortex of the juvenile rat , 2004, The Journal of physiology.
[95] H. Ueda,et al. A Possible Pathway of Phosphoinositide Metabolism Through EDTA‐Insensitive Phospholipase A1 Followed by Lysophosphoinositide‐Specific Phospholipase C in Rat Brain , 1993, Journal of neurochemistry.
[96] A. Ottani,et al. Learning Impairment Produced in Rats by the Cannabinoid Agonist HU 210 in a Water-Maze Task , 1999, Pharmacology Biochemistry and Behavior.
[97] C. Breivogel,et al. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. , 2001, Molecular pharmacology.
[98] J. Manzanares,et al. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors , 2004, Neuropharmacology.
[99] N. Volkow,et al. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. , 1996, European journal of pharmacology.
[100] R. Hawkins,et al. Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus. , 2002, Journal of neurophysiology.
[101] G. Perrault,et al. SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats , 2002, Behavioural pharmacology.
[102] Anatol C. Kreitzer,et al. Inhibition of Interneuron Firing Extends the Spread of Endocannabinoid Signaling in the Cerebellum , 2002, Neuron.
[103] David E Nichols,et al. Serotonin 5‐HT2A receptor activation induces 2‐arachidonoylglycerol release through a phospholipase c‐dependent mechanism , 2006, Journal of neurochemistry.
[104] K. Mackie,et al. Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line , 2008, British journal of pharmacology.
[105] H. Markram,et al. Neuropeptide and calcium‐binding protein gene expression profiles predict neuronal anatomical type in the juvenile rat , 2005, The Journal of physiology.
[106] K. Mackie,et al. A Key Role for Diacylglycerol Lipase-α in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization , 2007, Molecular Pharmacology.
[107] D. Julius,et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide , 1999, Nature.
[108] S. Snyder,et al. Brain phospholipase C isozymes: differential mRNA localizations by in situ hybridization. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[109] P. Schweitzer. Cannabinoids Decrease the K+ M-Current in Hippocampal CA1 Neurons , 2000, The Journal of Neuroscience.
[110] P. Schweitzer,et al. Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus , 2005, Neuropharmacology.
[111] M. Isokawa,et al. Activation of Muscarinic Acetylcholine Receptors Enhances the Release of Endogenous Cannabinoids in the Hippocampus , 2002, The Journal of Neuroscience.
[112] C. Yamamoto,et al. Properties of depolarization-induced suppression of inhibitory transmission in cultured rat hippocampal neurons , 1997, Pflügers Archiv.
[113] Masahiko Watanabe,et al. Tonic Enhancement of Endocannabinoid-Mediated Retrograde Suppression of Inhibition by Cholinergic Interneuron Activity in the Striatum , 2007, The Journal of Neuroscience.
[114] S. Di,et al. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. , 2005, Endocrinology.
[115] Wade G Regehr,et al. Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids , 2003, Nature Neuroscience.
[116] D. Woodward,et al. Prostamides (prostaglandin‐ethanolamides) and their pharmacology , 2008, British journal of pharmacology.
[117] S. Nakanishi,et al. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing rat , 1992, The Journal of comparative neurology.
[118] C. Vaughan,et al. Muscarinic Modulation of Synaptic Transmission via Endocannabinoid Signalling in the Rat Midbrain Periaqueductal Gray , 2008, Molecular Pharmacology.
[119] B. Sakmann,et al. Patch-clamp recordings from the soma and dendrites of neurons in brain slices using infrared video microscopy , 1993, Pflügers Archiv.
[120] P. Ferrara,et al. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. , 1996, Biochimica et biophysica acta.
[121] K. Mackie. Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength , 2006, International Journal of Obesity.
[122] M. Vekemans,et al. The rat phospholipase Cβ 4 gene is expressed at high abundance in cerebellar Purkinje cells , 1995, Neuroreport.
[123] Y. Usachev,et al. All-or-None Ca2+ Release from Intracellular Stores Triggered by Ca2+ Influx through Voltage-Gated Ca2+ Channels in Rat Sensory Neurons , 1997, The Journal of Neuroscience.
[124] L. Petrocellis,et al. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. , 1997, The Biochemical journal.
[125] S. Gaetani,et al. Modulation of anxiety through blockade of anandamide hydrolysis , 2003, Nature Medicine.
[126] J. F. Krey,et al. Endocannabinoids and related fatty acid derivatives in pain modulation. , 2002, Chemistry and physics of lipids.
[127] Z. Song,et al. CB1 cannabinoid receptor‐mediated neurite remodeling in mouse neuroblastoma N1E‐115 cells , 2001, Journal of neuroscience research.
[128] I. Módy,et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations , 2000, The European journal of neuroscience.
[129] M. Kano,et al. Presynaptic Inhibition Caused by Retrograde Signal from Metabotropic Glutamate to Cannabinoid Receptors , 2001, Neuron.
[130] Shiro Watanabe,et al. Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes , 1994, Neurochemical Research.
[131] R. Shigemoto,et al. Differential expression of calretinin and metabotropic glutamate receptor mGluR1α defines subsets of unipolar brush cells in mouse cerebellum , 2002, The Journal of comparative neurology.
[132] D. Gibson,et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.
[133] J. García-Sancho,et al. Fura-2 antagonises calcium-induced calcium release. , 2003, Cell calcium.
[134] T. Blackburn,et al. Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS , 2000, Neuropharmacology.
[135] A. Derbenev,et al. Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve , 2004, The Journal of physiology.
[136] V. Sandler,et al. Calcium-Induced Calcium Release Contributes to Action Potential-Evoked Calcium Transients in Hippocampal CA1 Pyramidal Neurons , 1999, The Journal of Neuroscience.
[137] Y. Kawaguchi,et al. Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[138] Vivien Chevaleyre,et al. Endocannabinoid-mediated synaptic plasticity in the CNS. , 2006, Annual review of neuroscience.
[139] K. Svoboda,et al. The Life Cycle of Ca2+ Ions in Dendritic Spines , 2002, Neuron.
[140] D. Cota,et al. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. , 2006, Endocrine reviews.
[141] K. Mackie,et al. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[142] A. Levey,et al. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[143] T. Freund,et al. Segregation of two endocannabinoid‐hydrolyzing enzymes into pre‐ and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala , 2004, The European journal of neuroscience.
[144] M. Shen,et al. Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures , 1996, The Journal of Neuroscience.
[145] J. Bockaert,et al. Functional coupling between ryanodine receptors and L-type calcium channels in neurons , 1996, Nature.
[146] T. Bisogno,et al. The endocannabinoid signalling system: Biochemical aspects , 2005, Pharmacology Biochemistry and Behavior.
[147] Andreas Zimmer,et al. The Cannabinoid CB1 Receptor Mediates Retrograde Signals for Depolarization-Induced Suppression of Inhibition in Cerebellar Purkinje Cells , 2002, The Journal of Neuroscience.
[148] Y. Zilberter,et al. Dendritic release of glutamate suppresses synaptic inhibition of pyramidal neurons in rat neocortex , 2000, The Journal of physiology.
[149] Cherif Boudaba,et al. Activity‐dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus , 2005, The Journal of physiology.
[150] A. Hoffman,et al. Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure , 2003, The Journal of Neuroscience.
[151] M. Pistis,et al. Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons , 2004, The Journal of Neuroscience.
[152] H. Bradshaw,et al. The expanding field of cannabimimetic and related lipid mediators , 2005, British journal of pharmacology.
[153] W. Regehr,et al. Short-term synaptic plasticity. , 2002, Annual review of physiology.
[154] Yannick Schwab,et al. Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain , 2004, The Journal of physiology.
[155] N. Sang,et al. PGE2 glycerol ester, a COX‐2 oxidative metabolite of 2‐arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons , 2006, The Journal of physiology.
[156] R. Tsien,et al. A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.
[157] A. Lichtman,et al. Evaluation of CB 1 Receptor Knockout Mice in the Morris Water Maze , 2002 .
[158] R. Duvoisin,et al. Retroinhibition of Presynaptic Ca2+ Currents by Endocannabinoids Released via Postsynaptic mGluR Activation at a Calyx Synapse , 2004, The Journal of Neuroscience.
[159] B. Cravatt,et al. The endogenous cannabinoid system and its role in nociceptive behavior. , 2004, Journal of neurobiology.
[160] D. Lovinger,et al. Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[161] C. Stricker,et al. The contribution of intracellular calcium stores to mEPSCs recorded in layer II neurones of rat barrel cortex , 2002, The Journal of physiology.
[162] A. Yamashita,et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.
[163] Y. Isomura,et al. Distinct temporal profiles of activity‐dependent calcium increase in pyramidal neurons of the rat visual cortex , 1999, The Journal of physiology.
[164] E. Levine,et al. Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex. , 2003, Journal of neurophysiology.
[165] A. Lichtman,et al. Evaluation of CB1 receptor knockout mice in the Morris water maze. , 2002, The Journal of pharmacology and experimental therapeutics.
[166] Y. Kubota,et al. Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex , 1994, Brain Research.
[167] F. Crépel,et al. Retrograde modulation of transmitter release by postsynaptic subtype 1 metabotropic glutamate receptors in the rat cerebellum , 2001, The Journal of physiology.
[168] Judit K. Makara,et al. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus , 2005, Nature Neuroscience.
[169] Joseph E LeDoux. Emotion circuits in the brain. , 2009, Annual review of neuroscience.
[170] Eric D. Young,et al. What's a cerebellar circuit doing in the auditory system? , 2004, Trends in Neurosciences.
[171] I. Soltesz,et al. Postsynaptic origin of CB1‐dependent tonic inhibition of GABA release at cholecystokinin‐positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus , 2007, The Journal of physiology.
[172] K. Vinod,et al. Role of the endocannabinoid system in depression and suicide. , 2006, Trends in pharmacological sciences.
[173] D. Fegley,et al. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[174] R. Malenka,et al. Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus , 1992, Neuron.
[175] V. Chapman,et al. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain , 2007, British journal of pharmacology.
[176] K. Mackie,et al. Short-Term Retrograde Inhibition of GABAergic Synaptic Currents in Rat Purkinje Cells Is Mediated by Endogenous Cannabinoids , 2002, The Journal of Neuroscience.
[177] E. Ponomarev,et al. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli , 2005, Journal of neurochemistry.
[178] Attila Losonczy,et al. Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[179] S. Almog,et al. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. , 1993, Journal of medicinal chemistry.
[180] A. Lichtman,et al. Endocannabinoids in cognition and dependence. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.
[181] Yasuo Kawaguchi,et al. Heterogeneity of phasic cholinergic signaling in neocortical neurons. , 2007, Journal of neurophysiology.
[182] N. Stella. Cannabinoid signaling in glial cells , 2004, Glia.
[183] Yue Wang,et al. Endocannabinoids facilitate the induction of LTP in the hippocampus , 2002, Nature Neuroscience.
[184] N. Stella,et al. ATP Induces a Rapid and Pronounced Increase in 2-Arachidonoylglycerol Production by Astrocytes, a Response Limited by Monoacylglycerol Lipase , 2004, The Journal of Neuroscience.
[185] H. Eichenbaum. Hippocampus Cognitive Processes and Neural Representations that Underlie Declarative Memory , 2004, Neuron.
[186] Garrett E. Alexander. Basal ganglia , 1998 .
[187] B. Szabo,et al. Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse , 2002, Neuroscience.
[188] R. Hampson,et al. Behaviorally relevant endocannabinoid action in hippocampus: dependence on temporal summation of multiple inputs , 2005, Behavioural pharmacology.
[189] E. Hare,et al. Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[190] J. Morrow,et al. The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[191] F. Karush,et al. Antibody affinity—III the role of multivalence , 1972 .
[192] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[193] S. Itohara,et al. Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice , 2006, Neurobiology of Disease.
[194] D. Piomelli,et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. , 1997, Science.
[195] S. Siegelbaum,et al. Altered Presynaptic Vesicle Release and Cycling during mGluR-Dependent LTD , 2002, Neuron.
[196] G. Marsicano,et al. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain , 1999, The European journal of neuroscience.
[197] Y. Morozov,et al. Post‐natal development of type 1 cannabinoid receptor immunoreactivity in the rat hippocampus , 2003, The European journal of neuroscience.
[198] K. Harris,et al. Three-Dimensional Relationships between Hippocampal Synapses and Astrocytes , 1999, The Journal of Neuroscience.
[199] F. Crépel,et al. Developmental changes in retrograde messengers involved in depolarization-induced suppression of excitation at parallel fiber-Purkinje cell synapses in rodents. , 2007, Journal of neurophysiology.
[200] Afia B Ali,et al. Presynaptic Inhibition of GABAA receptor-mediated unitary IPSPs by cannabinoid receptors at synapses between CCK-positive interneurons in rat hippocampus. , 2007, Journal of neurophysiology.
[201] W. Regehr,et al. Calcium Dependence of Retrograde Inhibition by Endocannabinoids at Synapses onto Purkinje Cells , 2003, The Journal of Neuroscience.
[202] Alcino J. Silva,et al. Memory Reconsolidation and Extinction Have Distinct Temporal and Biochemical Signatures , 2004, The Journal of Neuroscience.
[203] M. Herkenham,et al. Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[204] P. Castillo,et al. Heterosynaptic LTD of Hippocampal GABAergic Synapses A Novel Role of Endocannabinoids in Regulating Excitability , 2003, Neuron.
[205] A. Lichtman,et al. Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice , 2005, Psychopharmacology.
[206] F. Fonseca,et al. Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1 , 2008, Neuropharmacology.
[207] R. Nitsch,et al. The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells , 2006, Neuron.
[208] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors , 1985, Brain Research.
[209] Susana R. Neves,et al. Role of the Go/i signaling network in the regulation of neurite outgrowth. , 2006, Canadian journal of physiology and pharmacology.
[210] H. Fukui,et al. Postnatal expression of H1‐receptor mRNA in the rat brain: correlation to l‐histidine decarboxylase expression and local upregulation in limbic seizures , 1998, The European journal of neuroscience.
[211] K. Mackie,et al. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation , 1999, Neuroscience.
[212] Pierangelo Geppetti,et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[213] D. Simone,et al. Differential Effects of CB1 and Opioid Agonists on Two Populations of Adult Rat Dorsal Root Ganglion Neurons , 2004, The Journal of Neuroscience.
[214] O. Valverde,et al. Involvement of the endocannabinoid system in drug addiction , 2006, Trends in Neurosciences.
[215] T. Bonner,et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. , 2000, European journal of pharmacology.
[216] M. Kano,et al. Endocannabinoid signalling triggered by NMDA receptor‐mediated calcium entry into rat hippocampal neurons , 2007, The Journal of physiology.
[217] T. Tsumoto,et al. Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus , 2008, Proceedings of the National Academy of Sciences.
[218] F. Bermúdez-Silva,et al. The endocannabinoid system: physiology and pharmacology. , 2005, Alcohol and alcoholism.
[219] F. Rodríguez de Fonseca,et al. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety‐like responses in the rat , 1997, Neuroreport.
[220] A. Buriani,et al. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[221] D. Talmage,et al. Integration of Endocannabinoid and Leptin Signaling in an Appetite-Related Neural Circuit , 2005, Neuron.
[222] J. Putney,et al. The TRPC3/6/7 subfamily of cation channels. , 2003, Cell calcium.
[223] B. Alger,et al. Multiple mechanisms of endocannabinoid response initiation in hippocampus. , 2006, Journal of neurophysiology.
[224] M. Isokawa,et al. Ryanodine receptor regulates endogenous cannabinoid mobilization in the hippocampus. , 2006, Journal of neurophysiology.
[225] T. Hökfelt,et al. Distribution of alpha 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[226] C. Fowler. Possible involvement of the endocannabinoid system in the actions of three clinically used drugs. , 2004, Trends in pharmacological sciences.
[227] A. Marty,et al. Glutamate as a candidate retrograde messenger at interneurone‐Purkinje cell synapses of rat cerebellum. , 1996, The Journal of physiology.
[228] P. Calabresi,et al. Post-receptor mechanisms underlying striatal long-term depression , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[229] H. Akil,et al. Distribution of α 1a-, α 1b- and α 1d-adrenergic receptor mRNA in the rat brain and spinal cord , 1997, Journal of Chemical Neuroanatomy.
[230] J. Vanderhaeghen,et al. Age-related loss of cannabinoid receptor binding sites and mRNA in the rat striatum , 1992, Neuroscience Letters.
[231] M. Kano,et al. Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum , 2006, Neuroscience Research.
[232] S. Haj-Dahmane,et al. The Wake-Promoting Peptide Orexin-B Inhibits Glutamatergic Transmission to Dorsal Raphe Nucleus Serotonin Neurons through Retrograde Endocannabinoid Signaling , 2005, The Journal of Neuroscience.
[233] M. Herkenham,et al. Cannabinoid receptors undergo axonal flow in sensory nerves , 1999, Neuroscience.
[234] T. Akita,et al. Functional Triads Consisting of Ryanodine Receptors, Ca2+ Channels, and Ca2+-Activated K+ Channels in Bullfrog Sympathetic Neurons , 2000, The Journal of general physiology.
[235] H. Markram,et al. Regulation of Synaptic Efficacy by Coincidence of Postsynaptic APs and EPSPs , 1997, Science.
[236] T. Freund,et al. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia , 2006, Neuroscience.
[237] C. Funk,et al. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene , 1994, Nature.
[238] T. Freund,et al. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus , 2000, Neuroscience.
[239] W. Regehr,et al. Differential Expression of Posttetanic Potentiation and Retrograde Signaling Mediate Target-Dependent Short-Term Synaptic Plasticity , 2007, Neuron.
[240] A. Howlett,et al. Pharmacology of cannabinoid receptors. , 1995, Annual review of pharmacology and toxicology.
[241] J. Laitinen,et al. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. , 2007, Basic & clinical pharmacology & toxicology.
[242] M. Kathmann,et al. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.
[243] A. Levey,et al. Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype- specific antibodies , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[244] B. Alger,et al. Calcium dependence of depolarization‐induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons , 1999, The Journal of physiology.
[245] B. Alger,et al. Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus , 1999, Neuroscience.
[246] B. Sakmann,et al. Coincidence detection and changes of synaptic efficacy in spiny stellate neurons in rat barrel cortex , 1999, Nature Neuroscience.
[247] D. Feldman,et al. Timing-Based LTP and LTD at Vertical Inputs to Layer II/III Pyramidal Cells in Rat Barrel Cortex , 2000, Neuron.
[248] S. Snyder,et al. Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[249] R. Hampson,et al. Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus. , 2003, Journal of neurophysiology.
[250] L. Acsády,et al. Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus , 1997, Neuroscience.
[251] Alexandros Makriyannis,et al. Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome , 2008, Physiology & Behavior.
[252] R. Bertorelli,et al. CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanisms , 2006, The European journal of neuroscience.
[253] Wade G. Regehr,et al. Endocannabinoids Control the Induction of Cerebellar LTD , 2005, Neuron.
[254] A. Saghatelian,et al. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. , 2006, Biochemistry.
[255] Judit K. Makara,et al. Involvement of Nitric Oxide in Depolarization-Induced Suppression of Inhibition in Hippocampal Pyramidal Cells during Activation of Cholinergic Receptors , 2007, The Journal of Neuroscience.
[256] Paul F. Smith,et al. Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study , 2006, Neuroscience Letters.
[257] F. Mascagni,et al. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons , 2001, Neuroscience.
[258] S. McCune,et al. Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain , 1993, Neuroscience.
[259] H. Markram,et al. Physiology and anatomy of synaptic connections between thick tufted pyramidal neurones in the developing rat neocortex. , 1997, The Journal of physiology.
[260] R. Hampson,et al. Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture. , 1999, The Journal of pharmacology and experimental therapeutics.
[261] K. Mackie,et al. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current , 2008, Proceedings of the National Academy of Sciences.
[262] T. Freund,et al. CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons , 2005, Neuroscience.
[263] G. Riedel,et al. Functions of cannabinoid receptors in the hippocampus , 2002, Neuropharmacology.
[264] V. Marzo,et al. Endocannabinoid control of food intake and energy balance , 2005, Nature Neuroscience.
[265] M. Kano,et al. Heterosynaptic expression of depolarization-induced suppression of inhibition (DSI) in rat hippocampal cultures , 2000, Neuroscience Research.
[266] Masaki Tanaka,et al. Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist , 2006, Pain.
[267] D. Julius,et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.
[268] W. Zieglgänsberger,et al. The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.
[269] D. Linden,et al. Expression of Cerebellar Long-Term Depression Requires Postsynaptic Clathrin-Mediated Endocytosis , 2000, Neuron.
[270] P. Worley,et al. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[271] M. Guzmán,et al. Effects of cannabinoids on energy metabolism. , 1999, Life sciences.
[272] S. File,et al. Endocannabinoid system and stress and anxiety responses , 2005, Pharmacology Biochemistry and Behavior.
[273] I. Yamamoto,et al. Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells. , 1997, Journal of biochemistry.
[274] E. Marco,et al. Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats. , 2003, Pharmacology, biochemistry, and behavior.
[275] T. Blackburn,et al. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system , 1997, Neuroscience.
[276] L. Parsons,et al. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum , 1999, Nature Neuroscience.
[277] Marc Parmentier,et al. Distribution of cannabinoid receptor messenger RNA in the human brain: An in situ hybridization histochemistry with oligonucleotides , 1992, Neuroscience Letters.
[278] R Lujan,et al. Perisynaptic Location of Metabotropic Glutamate Receptors mGluR1 and mGluR5 on Dendrites and Dendritic Spines in the Rat Hippocampus , 1996, The European journal of neuroscience.
[279] Anatol C. Kreitzer,et al. Retrograde Inhibition of Presynaptic Calcium Influx by Endogenous Cannabinoids at Excitatory Synapses onto Purkinje Cells , 2001, Neuron.
[280] 山崎 美和子. Miniature synaptic events elicited by presynaptic Ca[2+] rise are selectively suppressed by cannabinoid receptor activation in cerebellar Purkinje cells , 2006 .
[281] P. Jonas,et al. Associative Long-Term Depression in the Hippocampus Is Dependent on Postsynaptic N-Type Ca2+ Channels , 2000, The Journal of Neuroscience.
[282] L. Petrocellis,et al. Phosphatidic Acid as the Biosynthetic Precursor of the Endocannabinoid 2‐Arachidonoylglycerol in Intact Mouse Neuroblastoma Cells Stimulated with Ionomycin , 1999, Journal of neurochemistry.
[283] M. Ito,et al. Cerebellar long-term depression: characterization, signal transduction, and functional roles. , 2001, Physiological reviews.
[284] Yan-Yi Peng. Ryanodine-Sensitive Component of Calcium Transients Evoked by Nerve Firing at Presynaptic Nerve Terminals , 1996, The Journal of Neuroscience.
[285] E. Barker,et al. Anandamide transport. , 2004, Pharmacology & therapeutics.
[286] R. Mechoulam,et al. CB 1 cannabinoid receptors are involved in neuroprotection via NF-jB inhibition , 2005 .
[287] J. Sullivan,et al. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. , 1999, Journal of neurophysiology.
[288] M. L. de Ceballos,et al. Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway* , 2002, The Journal of Biological Chemistry.
[289] A Konnerth,et al. Release and sequestration of calcium by ryanodine‐sensitive stores in rat hippocampal neurones , 1997, The Journal of physiology.
[290] S. Schiffmann,et al. Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system , 1991, The Journal of comparative neurology.
[291] K. Mackie,et al. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[292] S. Vandevoorde,et al. The Multiple Pathways of Endocannabinoid Metabolism: A Zoom Out , 2007, Chemistry & biodiversity.
[293] M. Poo,et al. Modulation of GABAergic Transmission by Activity via Postsynaptic Ca2+-Dependent Regulation of KCC2 Function , 2005, Neuron.
[294] D. Lovinger,et al. Emerging roles for endocannabinoids in long‐term synaptic plasticity , 2003, British journal of pharmacology.
[295] G. Buzsáki,et al. Interneurons of the hippocampus , 1998, Hippocampus.
[296] Masahiko Watanabe,et al. Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals , 2008, The Journal of Neuroscience.
[297] B. Connors,et al. Sensory experience modifies the short-term dynamics of neocortical synapses , 1999, Nature.
[298] L. Martin,et al. Heterogeneous susceptibility of GABAA receptor‐mediated IPSCs to depolarization‐induced suppression of inhibition in rat hippocampus , 2001, The Journal of physiology.
[299] B. Szabo,et al. Effects of Exogenous and Endogenous Cannabinoids on GABAergic Neurotransmission between the Caudate-Putamen and the Globus Pallidus in the Mouse , 2006, Journal of Pharmacology and Experimental Therapeutics.
[300] Carol A. Barnes,et al. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids , 1993, Neuron.
[301] J. Vanderhaeghen,et al. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry , 1992, Neuroscience.
[302] P. Somogyi,et al. The cisternal organelle as a Ca2+-storing compartment associated with GABAergic synapses in the axon initial segment of hippocampal pyramidal neurones , 1994, Experimental Brain Research.
[303] S. Carr,et al. Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.
[304] 伊藤 正男. The cerebellum and neural control , 1984 .
[305] S. Hestrin,et al. Electrical Coupling among Irregular-Spiking GABAergic Interneurons Expressing Cannabinoid Receptors , 2004, The Journal of Neuroscience.
[306] Y. Kubota,et al. Physiological and morphological identification of somatostatin- or vasoactive intestinal polypeptide-containing cells among GABAergic cell subtypes in rat frontal cortex , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[307] M. Barish,et al. Inositol 1,4,5-trisphosphate and ryanodine receptor distributions and patterns of acetylcholine- and caffeine-induced calcium release in cultured mouse hippocampal neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[308] E. J. Fletcher,et al. Blockade by sigma site ligands of high voltage‐activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones , 1995, British journal of pharmacology.
[309] S. Munro,et al. Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.
[310] B. Basavarajappa. Critical enzymes involved in endocannabinoid metabolism. , 2007, Protein and peptide letters.
[311] U. Misgeld,et al. Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra , 2003, Neuroscience.
[312] T. Freund,et al. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers , 2002, Neuropharmacology.
[313] R. Pertwee. GPR55: a new member of the cannabinoid receptor clan? , 2007, British journal of pharmacology.
[314] T. Groblewski,et al. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models , 2003, The European journal of neuroscience.
[315] K. Hsu,et al. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons , 2001, The Journal of physiology.
[316] K. Mackie,et al. Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain , 2006, Pain.
[317] B. Bloch,et al. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[318] I. Galve-Roperh,et al. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. , 1998, Molecular pharmacology.
[319] E. Levine,et al. Endocannabinoids Mediate Rapid Retrograde Signaling At Interneuron → Pyramidal Neuron Synapses of the Neocortex , 2003 .
[320] F. Lenz,et al. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. , 2004, Brain research. Molecular brain research.
[321] S. L. Patrick,et al. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity , 1998, Brain Research.
[322] Mark M. Rasenick,et al. Lipid raft microdomains and neurotransmitter signalling , 2007, Nature Reviews Neuroscience.
[323] E. Welker,et al. Neurons immunoreactive for vasoactive intestinal polypeptide in the rat primary somatosensory cortex: Morphology and spatial relationship to barrel‐related columns , 2000, The Journal of comparative neurology.
[324] S. Tonegawa,et al. Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice , 1994, Cell.
[325] R. Iyengar,et al. Cannabinoid Receptor-induced Neurite Outgrowth Is Mediated by Rap1 Activation through Gαo/i-triggered Proteasomal Degradation of Rap1GAPII* , 2005, Journal of Biological Chemistry.
[326] D. Piomelli,et al. Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor,N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain , 1997, The Journal of Neuroscience.
[327] M. Bear,et al. Molecular mechanism for loss of visual cortical responsiveness following brief monocular deprivation , 2003, Nature Neuroscience.
[328] K. Waku,et al. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.
[329] S. Sherman,et al. Ultrastructural Localization Suggests that Retinal and Cortical Inputs Access Different Metabotropic Glutamate Receptors in the Lateral Geniculate Nucleus , 1996, The Journal of Neuroscience.
[330] T. Freund,et al. Endocannabinoid transport tightly controls 2‐arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404 , 2004, The European journal of neuroscience.
[331] M. Isokawa,et al. Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell , 2005, The Journal of physiology.
[332] P. Calabresi,et al. Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors , 1997, The Journal of Neuroscience.
[333] John R. Huguenard,et al. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids , 2004, Nature.
[334] U. Hellman,et al. cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase , 1997, The Journal of Biological Chemistry.
[335] D. Lovinger,et al. Retrograde Endocannabinoid Signaling in a Postsynaptic Neuron/Synaptic Bouton Preparation from Basolateral Amygdala , 2005, The Journal of Neuroscience.
[336] C. Ledent,et al. A role for endocannabinoids in indomethacin-induced spinal antinociception. , 2002, European journal of pharmacology.
[337] D. Linden. The expression of cerebellar LTD in culture is not associated with changes in AMPA-receptor kinetics, agonist affinity, or unitary conductance , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[338] K. Mackie,et al. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system , 1998, Neuroscience.
[339] B. May. Role of the dorsal cochlear nucleus in the sound localization behavior of cats , 2000, Hearing Research.
[340] Y. Kawaguchi,et al. Selective cholinergic modulation of cortical GABAergic cell subtypes. , 1997, Journal of neurophysiology.
[341] D. Fortin,et al. Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. , 2004, Journal of neurophysiology.
[342] Saori Oka,et al. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. , 2006, Progress in lipid research.
[343] B. Alger. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids , 2002, Progress in Neurobiology.
[344] Jon T. Willie,et al. Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.
[345] R. Zucker,et al. Photolysis‐induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons , 2001, The Journal of physiology.
[346] R. Moratalla,et al. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia , 2003, Neuroscience.
[347] W. Singer,et al. Different voltage-dependent thresholds for inducing long-term depression and long-term potentiation in slices of rat visual cortex , 1990, Nature.
[348] H. Markram,et al. Calcium transients in dendrites of neocortical neurons evoked by single subthreshold excitatory postsynaptic potentials via low-voltage-activated calcium channels. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[349] H. Monyer,et al. Analysis of the effects of cannabinoids on identified synaptic connections in the caudate‐putamen by paired recordings in transgenic mice , 2006, The Journal of physiology.
[350] D. Osei-Hyiaman,et al. Evidence for novel cannabinoid receptors. , 2005, Pharmacology & therapeutics.
[351] L. Petrocellis,et al. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain , 2006, Neuroscience.
[352] W. Campbell,et al. Accumulation of N‐Arachidonoylethanolamine (Anandamide) into Cerebellar Granule Cells Occurs via Facilitated Diffusion , 1997, Journal of neurochemistry.
[353] D. Piomelli,et al. Structural determinants for recognition and translocation by the anandamide transporter. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[354] M. Brann,et al. Localization of a family of muscarinic receptor mRNAs in rat brain , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[355] L. Hunyady,et al. The Role of Diacylglycerol Lipase in Constitutive and Angiotensin AT1 Receptor-stimulated Cannabinoid CB1 Receptor Activity* , 2007, Journal of Biological Chemistry.
[356] T. Freund,et al. Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.
[357] A. Hoffman,et al. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus , 2003, The European journal of neuroscience.
[358] S. Tayebati,et al. Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries , 2003, Neuroscience.
[359] Gareth Williams,et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain , 2003, The Journal of cell biology.
[360] A. J. Lusis,et al. Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. , 2001, Gene.
[361] E. Levine,et al. Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. , 2002, Journal of neurophysiology.
[362] V. Pickel,et al. Ultrastructural Localization of the CB1 Cannabinoid Receptor in μ-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus , 2001, The Journal of Neuroscience.
[363] M. Kano,et al. Endocannabinoids and Synaptic Function in the CNS , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[364] G. Cossu,et al. An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives , 2007, Brain Research Reviews.
[365] T. Südhof,et al. Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α , 2007, Neuron.
[366] A Konnerth,et al. Ryanodine receptor‐mediated intracellular calcium release in rat cerebellar Purkinje neurones. , 1995, The Journal of physiology.
[367] Michela Matteoli,et al. Hardwiring the Brain: Endocannabinoids Shape Neuronal Connectivity , 2007, Science.
[368] T. Kaneko,et al. Extensive overlap of mu-opioid and nicotinic sensitivity in cortical interneurons. , 2007, Cerebral cortex.
[369] D. Standaert,et al. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[370] B. Alger,et al. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus , 2004, Nature Neuroscience.
[371] M. Notarnicola,et al. Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population , 2007, International Journal of Obesity.
[372] Masahiko Watanabe,et al. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[373] K. Mackie,et al. Cloning and molecular characterization of the rat CB2 cannabinoid receptor. , 2002, Biochimica et biophysica acta.
[374] C. Vadász,et al. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens , 2003, Journal of neurochemistry.
[375] Wade G. Regehr,et al. Local Interneurons Regulate Synaptic Strength by Retrograde Release of Endocannabinoids , 2006, The Journal of Neuroscience.
[376] M. J. Mattes,et al. Binding parameters of antibodies reacting with multivalent antigens: functional affinity or pseudo-affinity. , 1997, Journal of immunological methods.
[377] A. Hohmann,et al. Endocannabinoid mechanisms of pain modulation , 2006, The AAPS Journal.
[378] M. Elphick,et al. The neurobiology and evolution of cannabinoid signalling. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[379] K. Mackie,et al. Redistribution of CB1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: A comparison between the gray mouse lemur (Microcebus murinus, primates) and rat , 2005, Neuroscience.
[380] J. Rossier,et al. AMPA receptor subunits expressed by single purkinje cells , 1992, Neuron.
[381] D. P. Sutherland,et al. Role of acoustic striae in hearing: discrimination of sound-source elevation , 1998, Hearing Research.
[382] A I Basbaum,et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.
[383] Masahiko Watanabe,et al. Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum , 2007, The Journal of Neuroscience.
[384] D. Dewitt,et al. Characterization of inducible cyclooxygenase in rat brain , 1995, The Journal of comparative neurology.
[385] M. Elphick,et al. Comparative analysis of fatty acid amide hydrolase and cb1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling , 2003, Neuroscience.
[386] A. Barbáchano,et al. Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study , 2004, Synapse.
[387] A. Hoffman,et al. Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus , 2000, The Journal of Neuroscience.
[388] Robin Christensen,et al. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials , 2007, The Lancet.
[389] T. Bonner,et al. Localization of cannabinoid receptor mRNA in rat brain , 1993, The Journal of comparative neurology.
[390] Patricia H Reggio,et al. Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system. , 2005, Life sciences.
[391] S. McMahon,et al. Cannabinoid CB(1) receptor expression in rat spinal cord. , 2000, Molecular and cellular neurosciences.
[392] P. Belfrage,et al. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. , 1976, The Journal of biological chemistry.
[393] B. Alger,et al. Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others , 2008, Neuropharmacology.
[394] F. Crépel,et al. Developmental changes in agonist-induced retrograde signaling at parallel fiber-Purkinje cell synapses: role of calcium-induced calcium release. , 2007, Journal of neurophysiology.
[395] S. Nelson,et al. The NMDA-to-AMPA ratio at synapses onto layer 2/3 pyramidal neurons is conserved across prefrontal and visual cortices. , 2003, Journal of neurophysiology.
[396] M. Elphick,et al. Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry , 2003, Neuroscience.
[397] D. Fortin,et al. Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex , 2004, The Journal of physiology.
[398] B. Alger,et al. Retrograde signaling at GABAA-receptor synapses in the mammalian CNS , 1995, Trends in Neurosciences.
[399] H. Kondo,et al. Localization of mRNAs for three novel members (β3, β4 and γ2) of phospholipase C family in mature rat brain , 1994, Neuroscience Letters.
[400] M. Herkenham,et al. Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: A double‐label in situ hybridization study , 2000 .
[401] C. Flachskamm,et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. , 2003, The Journal of clinical investigation.
[402] E. Valjent,et al. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence , 2002, Neuropharmacology.
[403] S. Vicini,et al. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons , 1998, The Journal of physiology.
[404] Pedro Grandes,et al. Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex , 2007, PloS one.
[405] Chiayu Q. Chiu,et al. Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus , 2008, Neuropharmacology.
[406] M. Bouthenet,et al. A detailed mapping of hist amine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine , 1988, Neuroscience.
[407] F. Crépel,et al. Control of Ca2+ influx by cannabinoid and metabotropic glutamate receptors in rat cerebellar cortex requires K+ channels , 2001, The Journal of physiology.
[408] D. O. Hebb,et al. The organization of behavior , 1988 .
[409] T. Freund,et al. Long-Term Plasticity of Endocannabinoid Signaling Induced by Developmental Febrile Seizures , 2003, Neuron.
[410] K. Waku,et al. 2‐Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+‐dependent and ‐independent mechanisms , 1998, FEBS letters.
[411] M. Kano,et al. Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses , 2002, The Journal of Neuroscience.
[412] P. Castillo,et al. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus , 2006, Neuroscience.
[413] E. Milligan,et al. Cannabinoids for the treatment of neuropathic pain: clinical evidence. , 2008, Current opinion in investigational drugs.
[414] R F Thompson,et al. Memory systems in the brain and localization of a memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[415] S. Hjorth,et al. The orphan receptor GPR55 is a novel cannabinoid receptor , 2007, British journal of pharmacology.
[416] R. Nicoll,et al. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses , 2001, Nature.
[417] A. Howlett. Efficacy in CB1 receptor‐mediated signal transduction , 2004, British journal of pharmacology.
[418] B. Rocha,et al. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice , 2003, Behavioural pharmacology.
[419] M. Low,et al. Differential Regulation of Synaptic Inputs by Constitutively Released Endocannabinoids and Exogenous Cannabinoids , 2005, The Journal of Neuroscience.
[420] B. Robertson,et al. Presynaptic internal Ca2+ stores contribute to inhibitory neurotransmitter release onto mouse cerebellar Purkinje cells , 2002, British journal of pharmacology.
[421] C. Hansel,et al. Climbing Fiber-Evoked Endocannabinoid Signaling Heterosynaptically Suppresses Presynaptic Cerebellar Long-Term Potentiation , 2006, The Journal of Neuroscience.
[422] Z. Vogel,et al. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[423] M. Diana,et al. Group I Metabotropic Glutamate Receptors Inhibit GABA Release at Interneuron-Purkinje Cell Synapses through Endocannabinoid Production , 2004, The Journal of Neuroscience.
[424] R. Mechoulam,et al. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .
[425] K. Mackie,et al. Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors , 2005, Molecular Pharmacology.
[426] D. Price,et al. Cellular localizations of AMPA glutamate receptors within the basal forebrain magnocellular complex of rat and monkey , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[427] Vanessa A. Bender,et al. Two Coincidence Detectors for Spike Timing-Dependent Plasticity in Somatosensory Cortex , 2006, The Journal of Neuroscience.
[428] F. Crépel,et al. Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum , 2004, The Journal of physiology.
[429] N. Ueda,et al. Discovery and Characterization of a Ca2+-independent Phosphatidylethanolamine N-Acyltransferase Generating the Anandamide Precursor and Its Congeners* , 2006, Journal of Biological Chemistry.
[430] H. Markram,et al. Dendritic calcium transients evoked by single back‐propagating action potentials in rat neocortical pyramidal neurons. , 1995, The Journal of physiology.
[431] J. Rossier,et al. Properties of bipolar VIPergic interneurons and their excitation by pyramidal neurons in the rat neocortex , 1998, The European journal of neuroscience.
[432] K. Waku,et al. Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues. , 2000, Chemical & pharmaceutical bulletin.
[433] L. Petrocellis,et al. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. , 2001, European journal of biochemistry.
[434] M. Korbonits,et al. The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System , 2008, PloS one.
[435] J. Laitinen,et al. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors , 2003, British journal of pharmacology.
[436] G. Chaudhuri,et al. Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. , 1995, DNA sequence : the journal of DNA sequencing and mapping.
[437] P. Calabresi,et al. Long-term synaptic depression in the striatum: physiological and pharmacological characterization , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[438] R. Hampson,et al. Cannabinoid physiology and pharmacology: 30 years of progress , 2004, Neuropharmacology.
[439] T. Friede,et al. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis , 2005, Neurology.
[440] Lei Wang,et al. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[441] Masahiko Watanabe,et al. Phospholipase Cβ3 is distributed in both somatodendritic and axonal compartments and localized around perisynapse and smooth endoplasmic reticulum in mouse Purkinje cell subsets , 2007, The European journal of neuroscience.
[442] R. Langenbach,et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.
[443] C. Salio,et al. Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord , 2002, Neuroscience Letters.
[444] S. Ben-Shabat,et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury , 2001, Nature.
[445] R K Jain,et al. Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays. , 1992, Cancer research.
[446] D. Prince,et al. Cholinergic switching within neocortical inhibitory networks. , 1998, Science.
[447] B. Sakmann,et al. Spine Ca2+ Signaling in Spike-Timing-Dependent Plasticity , 2006, The Journal of Neuroscience.
[448] P. Bregestovski,et al. Dual Ca2+ modulation of glycinergic synaptic currents in rodent hypoglossal motoneurones , 2005, The Journal of physiology.
[449] Masahiko Watanabe,et al. Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus , 2008, The Journal of Neuroscience.
[450] G. Kunos,et al. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB 1 receptors on peripheral sympathetic nerves , 1996, British journal of pharmacology.
[451] K. Mackie,et al. Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones , 2005, The Journal of physiology.
[452] W. Campbell,et al. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. , 2004, Molecular pharmacology.
[453] Stephen P. Mayfield,et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides , 1996, Nature.
[454] J. Rossier,et al. Classification of fusiform neocortical interneurons based on unsupervised clustering. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[455] Masahiko Watanabe,et al. Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain , 2000, Neuroscience Letters.
[456] M. Herkenham,et al. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[457] Y. Smith,et al. Group I Metabotropic Glutamate Receptors in the Monkey Striatum: Subsynaptic Association with Glutamatergic and Dopaminergic Afferents , 2003, The Journal of Neuroscience.
[458] L. Iversen,et al. Cannabis and the brain. , 2003, Brain : a journal of neurology.
[459] S. Thayer,et al. Cannabinoids Inhibit the Formation of New Synapses between Hippocampal Neurons in Culture , 2001, The Journal of Neuroscience.
[460] A. Brown. Novel cannabinoid receptors , 2007, British journal of pharmacology.
[461] M. Parmentier,et al. Involvement of CB1 cannabinoid receptors in emotional behaviour , 2002, Psychopharmacology.
[462] N. Jamshidi,et al. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats , 2001, British journal of pharmacology.
[463] A. Howlett,et al. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. , 2000, Chemistry and physics of lipids.
[464] W. Regehr,et al. Sustained Elevation of Dendritic Calcium Evokes Widespread Endocannabinoid Release and Suppression of Synapses onto Cerebellar Purkinje Cells , 2006, The Journal of Neuroscience.
[465] D. Price,et al. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[466] Anatol C. Kreitzer,et al. Dopamine Modulation of State-Dependent Endocannabinoid Release and Long-Term Depression in the Striatum , 2005, The Journal of Neuroscience.
[467] G. Bi,et al. Synaptic Modifications in Cultured Hippocampal Neurons: Dependence on Spike Timing, Synaptic Strength, and Postsynaptic Cell Type , 1998, The Journal of Neuroscience.
[468] A. Makriyannis,et al. The Conformation, Location, and Dynamic Properties of the Endocannabinoid Ligand Anandamide in a Membrane Bilayer* , 2005, Journal of Biological Chemistry.
[469] C. Ledent,et al. Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis , 2008, Journal of Neuroimmunology.
[470] Alan Fine,et al. Calcium Stores in Hippocampal Synaptic Boutons Mediate Short-Term Plasticity, Store-Operated Ca2+ Entry, and Spontaneous Transmitter Release , 2001, Neuron.
[471] T. Mikkelsen,et al. A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals* , 2006, Journal of Biological Chemistry.
[472] Masahiko Watanabe,et al. Roles of phospholipase Cβ and NMDA receptor in activity‐dependent endocannabinoid release , 2007, The Journal of physiology.
[473] C. Ledent,et al. Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test , 2003, The European journal of neuroscience.
[474] David Robbe,et al. Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens , 2008, Neuropharmacology.
[475] S. Vandevoorde,et al. Lack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis in vitro , 2007, British journal of pharmacology.
[476] Michael Davis,et al. Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear , 2005, Neuropsychopharmacology.
[477] K. Mackie,et al. Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. , 2002, Chemistry and physics of lipids.
[478] R. Maldonado,et al. Regulation of PI3K/Akt/GSK‐3 pathway by cannabinoids in the brain , 2007, Journal of neurochemistry.
[479] L. Petrocellis,et al. The endocannabinoid system: a general view and latest additions , 2004, British journal of pharmacology.
[480] J. Penney,et al. Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons , 1995, The Journal of comparative neurology.
[481] Masahiko Watanabe,et al. Gq protein α subunits Gαq and Gα11 are localized at postsynaptic extra‐junctional membrane of cerebellar Purkinje cells and hippocampal pyramidal cells , 2000, The European journal of neuroscience.
[482] J. Špaček,et al. Three-Dimensional analysis of dendritic spines , 1983, Anatomy and Embryology.
[483] Hee-Sup Shin,et al. Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal , 2005, Neuron.
[484] C. Seva,et al. Cholecystokinin and gastrin receptors. , 2006, Physiological reviews.
[485] J. Geiger,et al. Presence and functional significance of presynaptic ryanodine receptors , 2003, Progress in Neurobiology.
[486] P. Castillo,et al. Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin , 2008, Proceedings of the National Academy of Sciences.
[487] D. Piomelli. The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.
[488] A. Lichtman,et al. Differential effects of Δ9-THC on spatial reference and working memory in mice , 2001, Psychopharmacology.
[489] M. Elphick,et al. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C‐terminal tail of CB1 , 2000, The Journal of comparative neurology.
[490] M. Glass,et al. CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.
[491] P. Somogyi,et al. Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1α, mGluR2 and mGluR5, relative to neurotransmitter release sites , 1997, Journal of Chemical Neuroanatomy.
[492] K. Stratford,et al. Presynaptic release probability influences the locus of long-term potentiation , 1992, Nature.
[493] P. Robledo,et al. Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration , 2005, Neuropsychopharmacology.
[494] K. Perry,et al. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions , 2003, British journal of pharmacology.
[495] J. Rossier,et al. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. , 2007, Journal of neurophysiology.
[496] B. Alger,et al. Differential effects of the group II mGluR agonist, DCG‐IV, on depolarization‐induced suppression of inhibition in hippocampal CA1 and CA3 neurons , 2000, Hippocampus.
[497] D. Fortin,et al. Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. , 2006, Cerebral cortex.
[498] Masahiko Watanabe,et al. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area , 2008, Neuropharmacology.
[499] Anatol C. Kreitzer,et al. Mechanisms for Synapse Specificity during Striatal Long-Term Depression , 2007, The Journal of Neuroscience.
[500] J. Girault,et al. Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide , 1996, Science.
[501] L. Forman. The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801 , 2003, Brain Research Bulletin.
[502] P. Castillo,et al. Endocannabinoid-Mediated Metaplasticity in the Hippocampus , 2004, Neuron.
[503] A. Levey,et al. Differential presynaptic and postsynaptic expression of m1–m4 muscarinic acetylcholine receptors at the perforant pathway/granule cell synapse , 1998, Neuroscience.
[504] E. Cudaback,et al. Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells , 2007, The Journal of Neuroscience.
[505] M. Herkenham,et al. Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains , 1994, Neuroscience.
[506] K. Mackie. Cannabinoid receptor homo- and heterodimerization. , 2005, Life sciences.
[507] A. Destexhe,et al. The high-conductance state of neocortical neurons in vivo , 2003, Nature Reviews Neuroscience.
[508] R. Treede,et al. Co-expression of the voltage-gated potassium channel Kv1.4 with transient receptor potential channels (TRPV1 and TRPV2) and the cannabinoid receptor CB1 in rat dorsal root ganglion neurons , 2006, Neuroscience.
[509] R. Miguel,et al. Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters , 2001, Pharmacology Biochemistry and Behavior.
[510] R. Elde,et al. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites , 1999, The European journal of neuroscience.
[511] Shigetada Nakanishi,et al. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain , 1993, Neuroscience Letters.
[512] J. Parnavelas,et al. Extensive co-existence of neuropeptides in the rat visual cortex , 1987, Brain Research.
[513] P. Soubrié,et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor , 1994, FEBS letters.
[514] Masahiko Watanabe,et al. Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase Cβ in mouse brain , 1998, The European journal of neuroscience.
[515] K. Mackie,et al. Identification functional characterization of brainstem cannabinoid CB2 receptors. , 2022 .
[516] Anatol C. Kreitzer,et al. Cerebellar Depolarization-Induced Suppression of Inhibition Is Mediated by Endogenous Cannabinoids , 2001, The Journal of Neuroscience.
[517] T. Freund,et al. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety , 2002, The European journal of neuroscience.
[518] D. Lovinger,et al. Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity. , 2007, Journal of neurophysiology.
[519] S. Oliet,et al. Retrograde Regulation of GABA Transmission by the Tonic Release of Oxytocin and Endocannabinoids Governs Postsynaptic Firing , 2007, The Journal of Neuroscience.
[520] A. Schoffelmeer,et al. Cannabinoid CB1 receptors control conditioned drug seeking. , 2005, Trends in pharmacological sciences.
[521] George Kunos,et al. Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus , 2001, Neuron.
[522] Masanobu Kano,et al. Ca2+-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities , 2007, Current Opinion in Neurobiology.
[523] R. Llinás,et al. Different calcium channels mediate transmitter release evoked by transient or sustained depolarization at mammalian symphatetic ganglia , 1995, Neuroscience.
[524] E. V. Bockstaele,et al. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex , 2005, Brain Research.
[525] L. Trussell,et al. Cell-specific, spike timing–dependent plasticities in the dorsal cochlear nucleus , 2004, Nature Neuroscience.
[526] Anatol C. Kreitzer,et al. Retrograde signaling by endocannabinoids , 2002, Current Opinion in Neurobiology.
[527] D. Faber,et al. Applicability of the coefficient of variation method for analyzing synaptic plasticity. , 1991, Biophysical journal.
[528] M. Parmentier,et al. Nucleotide sequence of a human cannabinoid receptor cDNA. , 1990, Nucleic acids research.
[529] K. Waku,et al. 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. , 2002, Archives of biochemistry and biophysics.
[530] D. Lovinger,et al. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum , 2002, Nature Neuroscience.
[531] M. Whittington,et al. A Novel Network of Multipolar Bursting Interneurons Generates Theta Frequency Oscillations in Neocortex , 2003, Neuron.
[532] M. Kano,et al. Endogenous Cannabinoid Signaling through the CB1 Receptor Is Essential for Cerebellum-Dependent Discrete Motor Learning , 2006, The Journal of Neuroscience.
[533] K. Mackie,et al. Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk? , 2005, Molecular Pharmacology.
[534] R. Gibbs,et al. A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide* , 2004, Journal of Biological Chemistry.
[535] N. Ueda,et al. Biosynthetic Pathways of the Endocannabinoid Anandamide , 2007, Chemistry & biodiversity.
[536] K. Waku,et al. Ether‐linked analogue of 2‐arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species , 2003, Journal of neurochemistry.
[537] D. Uhlrich,et al. Muscarinic receptor subtypes in the lateral geniculate nucleus: A light and electron microscopic analysis , 1999, The Journal of comparative neurology.
[538] A. Makriyannis,et al. How lipophilic cannabinergic ligands reach their receptor sites. , 2005, Prostaglandins & other lipid mediators.
[539] A. Marty,et al. Endocannabinoid‐mediated short‐term synaptic plasticity: depolarization‐induced suppression of inhibition (DSI) and depolarization‐induced suppression of excitation (DSE) , 2004, British journal of pharmacology.
[540] A. Araque,et al. Endocannabinoids Mediate Neuron-Astrocyte Communication , 2008, Neuron.
[541] B. Cravatt,et al. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300475-JLR200 , 2004, Journal of Lipid Research.
[542] F. Drago,et al. Endocannabinoids and neurodegenerative diseases. , 2007, Pharmacological research.
[543] Q. Pittman,et al. Talking back: dendritic neurotransmitter release , 2003, Trends in Neurosciences.
[544] S. Nigam,et al. Biochemistry and pharmacology of endovanilloids. , 2007, Pharmacology & therapeutics.
[545] T. Tsumoto,et al. Roles of Endocannabinoids in Heterosynaptic Long-Term Depression of Excitatory Synaptic Transmission in Visual Cortex of Young Mice , 2008, The Journal of Neuroscience.
[546] D. Centonze,et al. Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons , 2007, Molecular and Cellular Neuroscience.
[547] E. Tzavara,et al. A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders. , 2005, Trends in pharmacological sciences.
[548] R. Nicoll,et al. Two Distinct Forms of Long-Term Depression Coexist in CA1 Hippocampal Pyramidal Cells , 1997, Neuron.
[549] Sean P. Brown,et al. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. , 1997, Journal of neurophysiology.
[550] M. Häring,et al. Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice , 2007, Neuroscience.
[551] Beat Lutz,et al. Circuitry for Associative Plasticity in the Amygdala Involves Endocannabinoid Signaling , 2004, The Journal of Neuroscience.
[552] L. Cooper,et al. A unified model of NMDA receptor-dependent bidirectional synaptic plasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[553] M. Eder,et al. CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.
[554] E. B. Roberts,et al. Enhanced NR2A subunit expression and decreased NMDA receptor decay time at the onset of ocular dominance plasticity in the ferret. , 1999, Journal of neurophysiology.
[555] M. Elphick,et al. Localization of N‐acyl phosphatidylethanolamine phospholipase D (NAPE‐PLD) expression in mouse brain: A new perspective on N‐acylethanolamines as neural signaling molecules , 2008, The Journal of comparative neurology.
[556] T. Bonner,et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.
[557] P. Casellas,et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. , 1998, The Journal of pharmacology and experimental therapeutics.
[558] Y. Kawaguchi,et al. Groupings of nonpyramidal and pyramidal cells with specific physiological and morphological characteristics in rat frontal cortex. , 1993, Journal of neurophysiology.
[559] G. Augustine,et al. Local Calcium Signaling in Neurons , 2003, Neuron.
[560] T. Freund,et al. Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.
[561] Robert C. Malenka,et al. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models , 2007, Nature.
[562] M. Kano,et al. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation , 2002, The European journal of neuroscience.
[563] B. Salzberg,et al. Caffeine interaction with fluorescent calcium indicator dyes. , 1999, Biophysical journal.
[564] D. Lovinger,et al. Disruption of Endocannabinoid Release and Striatal Long-Term Depression by Postsynaptic Blockade of Endocannabinoid Membrane Transport , 2004, The Journal of Neuroscience.
[565] B. Cravatt,et al. A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.
[566] Niklas Larsson,et al. Identification and characterisation of a novel splice variant of the human CB1 receptor , 2005, FEBS letters.
[567] D. Linden,et al. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. , 2000, Journal of neurophysiology.
[568] B. Alger,et al. N‐ and L‐type calcium channel involvement in depolarization‐induced suppression of inhibition in rat hippocampal CA1 cells , 1998, The Journal of physiology.
[569] Henry H. Yin,et al. Dopaminergic Control of Corticostriatal Long-Term Synaptic Depression in Medium Spiny Neurons Is Mediated by Cholinergic Interneurons , 2006, Neuron.
[570] P. Delmas,et al. Signaling Microdomains Define the Specificity of Receptor-Mediated InsP3 Pathways in Neurons , 2002, Neuron.
[571] C. Ramesha,et al. Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2* , 1997, The Journal of Biological Chemistry.
[572] S. Snyder,et al. Characterization of inositol trisphosphate receptor binding in brain. Regulation by pH and calcium. , 1987, The Journal of biological chemistry.
[573] Edith Hamel,et al. 5-HT3 Receptors Mediate Serotonergic Fast Synaptic Excitation of Neocortical Vasoactive Intestinal Peptide/Cholecystokinin Interneurons , 2002, The Journal of Neuroscience.
[574] N. Sang,et al. COX‐2 oxidative metabolite of endocannabinoid 2‐AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity , 2007, Journal of neurochemistry.
[575] K. Deisseroth,et al. CREB Phosphorylation and Dephosphorylation: A Ca2+- and Stimulus Duration–Dependent Switch for Hippocampal Gene Expression , 1996, Cell.
[576] Paul Antoine Salin,et al. Cyclic AMP Mediates a Presynaptic Form of LTP at Cerebellar Parallel Fiber Synapses , 1996, Neuron.
[577] Masanobu Kano,et al. Synaptically Driven Endocannabinoid Release Requires Ca2+-Assisted Metabotropic Glutamate Receptor Subtype 1 to Phospholipase C β4 Signaling Cascade in the Cerebellum , 2005, The Journal of Neuroscience.
[578] A. Marty,et al. Neighboring cerebellar purkinje cells communicate via retrograde inhibition of common presynaptic interneurons , 1993, Neuron.
[579] S. Gaetani,et al. Anandamide hydrolysis: a new target for anti-anxiety drugs? , 2003, Trends in molecular medicine.
[580] M. Pompeiano,et al. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.
[581] Beat Lutz,et al. Cannabinoid CB1 Receptor Mediates Fear Extinction via Habituation-Like Processes , 2006, The Journal of Neuroscience.
[582] Y. Jan,et al. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex , 1994, Nature.
[583] Ken Mackie,et al. Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons , 1999, The Journal of Neuroscience.
[584] Greg D. Gale,et al. Hippocampus and contextual fear conditioning: Recent controversies and advances , 2001, Hippocampus.
[585] B. Lutz,et al. Further evidence for the existence of a specific process for the membrane transport of anandamide. , 2004, The Biochemical journal.
[586] D. Lovinger,et al. Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling , 2008, Neuropharmacology.
[587] Wade G. Regehr,et al. Timing dependence of the induction of cerebellar LTD , 2008, Neuropharmacology.
[588] J. Liebeskind,et al. Opioid and nonopioid mechanisms of stress analgesia. , 1980, Science.
[589] Yasuo Kawaguchi,et al. Two distinct subgroups of cholecystokinin-immunoreactive cortical interneurons , 1997, Brain Research.
[590] David Robbe,et al. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[591] P. J. Sjöström,et al. Endocannabinoid-dependent neocortical layer-5 LTD in the absence of postsynaptic spiking. , 2004, Journal of neurophysiology.
[592] I. Lizasoain,et al. The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn Rats , 2007, Pediatric Research.
[593] M. Herkenham,et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.
[594] N. Ueda,et al. Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.
[595] P. Soubrié,et al. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. , 2000, Journal of neurophysiology.
[596] C. Frazier,et al. Endocannabinoid-mediated depolarization-induced suppression of inhibition in hilar mossy cells of the rat dentate gyrus. , 2006, Journal of neurophysiology.
[597] S. Goldberg,et al. Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences , 2004, Neuroreport.
[598] Mariko Miyata,et al. Deficient long‐term synaptic depression in the rostral cerebellum correlated with impaired motor learning in phospholipase C β4 mutant mice , 2001, The European journal of neuroscience.
[599] M. Pistis,et al. Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors , 2004, The Journal of Neuroscience.
[600] D. Piomelli,et al. RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol , 2004, Molecular Pharmacology.
[601] C. Salio,et al. Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord , 2002, Neuroscience.
[602] M. Herkenham,et al. Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. , 2000, Synapse.
[603] M. Herkenham,et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[604] I. McGregor,et al. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol , 2004, Brain Research.
[605] W. Wetsel,et al. Regulation of gonadotropin-releasing hormone secretion by cannabinoids. , 2005, Endocrinology.
[606] B. Martin,et al. Cannabis: pharmacology and toxicology in animals and humans. , 1996, Addiction.
[607] Yuri Zilberter,et al. Endocannabinoid-Independent Retrograde Signaling at Inhibitory Synapses in Layer 2/3 of Neocortex: Involvement of Vesicular Glutamate Transporter 3 , 2004, The Journal of Neuroscience.
[608] R. Hampson,et al. Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons. , 1995, Life sciences.
[609] Pierre Casellas,et al. Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor , 2003, Journal of Biological Chemistry.
[610] C. Fowler. The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action , 2007, British journal of pharmacology.
[611] K. Mackie,et al. Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input‐specific retrograde signalling by cholinergic neurons , 2003, The European journal of neuroscience.
[612] F. Bymaster,et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. , 2002, The Journal of pharmacology and experimental therapeutics.
[613] T. Möller,et al. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[614] M. Kano,et al. Phospholipase cbeta4 is specifically involved in climbing fiber synapse elimination in the developing cerebellum. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[615] Y. Dan,et al. Spike Timing-Dependent Plasticity of Neural Circuits , 2004, Neuron.
[616] W. Bremner,et al. Advances in male contraception. , 2008, Endocrine reviews.
[617] A. Molleman,et al. Cannabinoid signalling. , 2006, Life sciences.
[618] M. Millan,et al. The neurobiology and control of anxious states , 2003, Progress in Neurobiology.
[619] R. Prediger,et al. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats , 2006, Psychopharmacology.
[620] M. Bear,et al. Homosynaptic long-term depression in the visual cortex , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[621] Vanessa A. Bender,et al. Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex , 2007, Neuroscience.
[622] A. Marty,et al. Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents , 1991, Neuron.
[623] J. Rossier,et al. Selective Excitation of Subtypes of Neocortical Interneurons by Nicotinic Receptors , 1999, The Journal of Neuroscience.
[624] Wade G. Regehr,et al. Associative Short-Term Synaptic Plasticity Mediated by Endocannabinoids , 2005, Neuron.
[625] Y. Dan,et al. Spike-timing-dependent synaptic modification induced by natural spike trains , 2002, Nature.
[626] A. Burkhalter,et al. Three distinct families of GABAergic neurons in rat visual cortex. , 1997, Cerebral cortex.
[627] M. C. Angulo,et al. Molecular and Physiological Diversity of Cortical Nonpyramidal Cells , 1997, The Journal of Neuroscience.
[628] M. Pistis,et al. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons , 2006, The European journal of neuroscience.
[629] D. Piomelli,et al. A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.
[630] T. Freund,et al. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus , 2001, Neuroscience.
[631] D. Deutsch,et al. Evidence against the presence of an anandamide transporter , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[632] R. Puffenbarger,et al. Genetic Polymorphisms of the Endocannabinoid System , 2007, Chemistry & biodiversity.
[633] S. Di,et al. Nongenomic Glucocorticoid Inhibition via Endocannabinoid Release in the Hypothalamus: A Fast Feedback Mechanism , 2003, The Journal of Neuroscience.
[634] Alberto Rábano,et al. Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains , 2003, The Journal of Neuroscience.
[635] S. Kirov,et al. Evidence for Metabotropic Glutamate Receptor Activation in the Induction of Depolarization-Induced Suppression of Inhibition in Hippocampal CA1 , 1998, The Journal of Neuroscience.
[636] David Robbe,et al. Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens , 2001, The Journal of Neuroscience.
[637] P. Beaulieu,et al. The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors. , 2007, European journal of pharmacology.
[638] Tamás F. Freund,et al. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2 , 2008, Neuropharmacology.
[639] P. Soubrié,et al. Cannabinoids decrease excitatory synaptic transmission and impair long‐term depression in rat cerebellar Purkinje cells , 1998, The Journal of physiology.
[640] Ivan Soltesz,et al. Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures , 2007, The Journal of Neuroscience.
[641] R. Spencer,et al. Immunohistochemical localization of the neural cannabinoid receptor in rat brain , 1998, Journal of neuroscience research.
[642] H. Ujike,et al. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. , 2004, Journal of pharmacological sciences.
[643] J. Walker,et al. Pain modulation by release of the endogenous cannabinoid anandamide. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[644] M. Staufenbiel,et al. Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera , 1995, Neuropharmacology.
[645] M. Pistis,et al. Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study , 2002, Brain Research.
[646] J. Schwartz,et al. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates , 1990, Brain Research.
[647] A. Argiolas,et al. Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: Immunocytochemistry, autoradiography and behavioral studies , 2007, Neuroscience.
[648] M. Kano,et al. Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus , 2003, The European journal of neuroscience.
[649] P. J. Sjöström,et al. Neocortical LTD via Coincident Activation of Presynaptic NMDA and Cannabinoid Receptors , 2003, Neuron.
[650] P. Casellas,et al. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. , 1995, The Biochemical journal.
[651] N. Birdsall,et al. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.
[652] J. Palacios,et al. Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry , 1990, Neuroscience Letters.
[653] J. Laitinen,et al. URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain. , 2006, Chemistry & biology.
[654] Z. Vogel,et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.
[655] Jennifer A. Geaga,et al. URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. , 2007, Chemistry & biology.
[656] P. Kostyuk,et al. Calcium stores in neurons and glia , 1994, Neuroscience.
[657] B. Alger,et al. Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus , 2001, The Journal of Neuroscience.
[658] Craig Weiss,et al. Hippocampal lesions prevent trace eyeblink conditioning in the freely moving rat , 1999, Behavioural Brain Research.
[659] M. Herkenham,et al. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study , 1999, Neuroscience.
[660] J. Laitinen,et al. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. , 2004, Biochemical pharmacology.
[661] G. Griffin,et al. Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor. , 2000, The Journal of pharmacology and experimental therapeutics.
[662] Y. Kubota,et al. Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin- and calbindinD28k-immunoreactive neurons in layer V of rat frontal cortex. , 1993, Journal of neurophysiology.
[663] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.
[664] D. Lovinger,et al. Induction of striatal long‐term synaptic depression by moderate frequency activation of cortical afferents in rat , 2005, The Journal of physiology.
[665] T. Freund,et al. Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[666] A. Levey,et al. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[667] M. Kano,et al. mGluR1 in cerebellar Purkinje cells is required for normal association of temporally contiguous stimuli in classical conditioning , 2002, The European journal of neuroscience.
[668] T. Bonner,et al. A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. , 1996, Molecular pharmacology.
[669] D. Lovinger,et al. Decreased Frequency But Not Amplitude of Quantal Synaptic Responses Associated with Expression of Corticostriatal Long-Term Depression , 1997, The Journal of Neuroscience.
[670] V. Marzo,et al. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol , 2002, British journal of pharmacology.
[671] Ian Duguid,et al. Retrograde activation of presynaptic NMDA receptors enhances GABA release at cerebellar interneuron–Purkinje cell synapses , 2004, Nature Neuroscience.
[672] S. Kawahara,et al. Impaired delay but normal trace eyeblink conditioning in PLCβ4 mutant mice , 2001, Neuroreport.
[673] M. Ussher,et al. Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. , 2007, The Cochrane database of systematic reviews.
[674] Michael Fill,et al. Ryanodine receptor calcium release channels. , 2002, Physiological reviews.
[675] A. Marty,et al. Presynaptic Ryanodine-Sensitive Calcium Stores Contribute to Evoked Neurotransmitter Release at the Basket Cell-Purkinje Cell Synapse , 2003, The Journal of Neuroscience.
[676] M. Kano,et al. Endogenous Cannabinoids Mediate Retrograde Signals from Depolarized Postsynaptic Neurons to Presynaptic Terminals , 2001, Neuron.
[677] G. Wang,et al. An R-Type Ca2+ Current in Neurohypophysial Terminals Preferentially Regulates Oxytocin Secretion , 1999, The Journal of Neuroscience.
[678] R. Pertwee. Pharmacology of cannabinoid CB1 and CB2 receptors. , 1997, Pharmacology & therapeutics.
[679] A. Molleman,et al. Cannabinoid signalling (review) , 2006 .
[680] C. Vaughan,et al. Glutamate Spillover Modulates GABAergic Synaptic Transmission in the Rat Midbrain Periaqueductal Grey via Metabotropic Glutamate Receptors and Endocannabinoid Signaling , 2008, The Journal of Neuroscience.
[681] John A. Peters,et al. The 5-HT3B subunit is a major determinant of serotonin-receptor function , 1999, Nature.
[682] B. Alger,et al. Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[683] R. E. Brown,et al. Cannabinoid modulation of rat pup ultrasonic vocalizations. , 1996, European journal of pharmacology.
[684] M. Parmentier,et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.
[685] P. Somogyi,et al. Subsynaptic segregation of metabotropic and ionotropic glutamate receptors as revealed by immunogold localization , 1994, Neuroscience.
[686] Tiziana Bisogno,et al. Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerol , 2006, The Journal of physiology.
[687] M. Kano,et al. Miniature Synaptic Events Elicited by Presynaptic Ca2+ Rise Are Selectively Suppressed by Cannabinoid Receptor Activation in Cerebellar Purkinje Cells , 2006, The Journal of Neuroscience.
[688] Y. Kawaguchi. Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer II/III of rat frontal cortex , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[689] L. Trussell,et al. Coactivation of Pre- and Postsynaptic Signaling Mechanisms Determines Cell-Specific Spike-Timing-Dependent Plasticity , 2007, Neuron.
[690] Ken Mackie,et al. Endocannabinoid Signaling in Rat Somatosensory Cortex: Laminar Differences and Involvement of Specific Interneuron Types , 2005, The Journal of Neuroscience.
[691] R. Palmiter,et al. Leptin-regulated endocannabinoids are involved in maintaining food intake , 2001, Nature.
[692] E. Onaivi. Neuropsychobiological Evidence for the Functional Presence and Expression of Cannabinoid CB2 Receptors in the Brain , 2007, Neuropsychobiology.
[693] B. Gorzalka,et al. Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test , 2005, European Neuropsychopharmacology.
[694] S. McMahon,et al. Cannabinoid CB1 Receptor Expression in Rat Spinal Cord , 2000, Molecular and Cellular Neuroscience.
[695] D. Selley,et al. Inhibitory effects of SR141716A on G-protein activation in rat brain. , 2001, European journal of pharmacology.
[696] K. Jin,et al. Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures , 1999, The Journal of Neuroscience.
[697] D. Piomelli,et al. Control of pain initiation by endogenous cannabinoids , 1998, Nature.
[698] P. Somogyi,et al. Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[699] C. Fowler,et al. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? , 2002, Prostaglandins, leukotrienes, and essential fatty acids.
[700] C. Glass,et al. The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a 5-HT3B Receptor Subunit* , 1999, The Journal of Biological Chemistry.
[701] D. Centonze,et al. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum , 2008, Nature Neuroscience.
[702] E. Falkenstein,et al. Multiple actions of steroid hormones--a focus on rapid, nongenomic effects. , 2000, Pharmacological reviews.
[703] Z. Bashir,et al. Different forms of LTD in the CA1 region of the hippocampus: role of age and stimulus protocol , 2000, The European journal of neuroscience.
[704] Masahiko Watanabe,et al. Distribution of type 1 cannabinoid receptor (CB1)‐immunoreactive axons in the mouse hypothalamus , 2007, The Journal of comparative neurology.
[705] D. Baker,et al. In silico patent searching reveals a new cannabinoid receptor. , 2006, Trends in pharmacological sciences.
[706] B. Alger,et al. Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism , 1994, Neuron.
[707] I. Díaz-Laviada,et al. Signal transduction activated by cannabinoid receptors. , 2005, Mini reviews in medicinal chemistry.
[708] J. Palacios,et al. The distribution of histamine H1-receptors in the rat brain: An autoradiographic study , 1981, Neuroscience.
[709] Masahiko Watanabe,et al. Predominant expression of phospholipase Cβ1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements , 2008, The European journal of neuroscience.
[710] G. Shepherd. The Synaptic Organization of the Brain , 1979 .
[711] D. Muller,et al. A simple method for organotypic cultures of nervous tissue , 1991, Journal of Neuroscience Methods.
[712] L. Acsády,et al. Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission , 2001, The Journal of Neuroscience.